SNOW · Snowflake Inc. · Insider Trading
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-10-21 | Dageville Benoit |
Director, Founder and Chief Architect |
Sell↓
Filing footnotes — Common Stock (Indirect)
The gift and sale reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
50,000 |
| 2026-10-21 | Dageville Benoit |
Director, Founder and Chief Architect |
Gift↓
Filing footnotes — Common Stock (Indirect)
The gift and sale reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
16,668 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $315.760 to $316.755, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
68,376 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $313.755 to $314.750, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
22,761 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $311.725 to $312.690, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
11,959 |
| 2026-10-19 | Slootman Frank |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
300,000 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $318.830 to $319.820, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
14,510 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $310.705 to $311.695, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in these footnotes. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
9,220 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $319.860 to $320.270, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
6,310 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $312.745 to $313.680, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
4,250 |
| 2026-10-19 | Slootman Frank |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The stock option is fully vested. |
Stock Option (Right to Buy)
|
300,000 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $317.760 to $318.745, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
39,298 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $314.760 to $315.750, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
40,896 |
| 2026-10-19 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $316.760 to $317.750, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
82,420 |
| 2026-10-07 | Dageville Benoit |
Director, Founder and Chief Architect |
Gift↓
Filing footnotes — Common Stock (Indirect)
The gift and sale reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
16,668 |
| 2026-10-07 | Dageville Benoit |
Director, Founder and Chief Architect |
Sell↓
Filing footnotes — Common Stock (Indirect)
The gift and sale reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
50,000 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
840 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Includes shares to be issued in connection with the vesting of one or more restricted stock units. The Reporting Person shares pecuniary interest in these shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares. |
Common Stock
|
403 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
12,973 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
840 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
34,005 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
840 |
| 2026-10-02 | Speiser Michael L |
Director |
Sell↓
Filing footnotes — Common Stock (Indirect)
Shares were sold pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 27, 2024. Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein. |
Common Stock
(I)
|
840 |
| 2026-10-01 | Kleinerman Christian |
EVP, Product Management |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
15,000 |
| 2026-09-23 | Beaulier Jonathan Mead |
Chief Revenue Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
755 |
| 2026-09-23 | Dageville Benoit |
Director, Founder and Chief Architect |
Sell↓
Filing footnotes — Common Stock (Indirect)
The sale and gift reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
50,000 |
| 2026-09-23 | Dageville Benoit |
Director, Founder and Chief Architect |
Gift↓
Filing footnotes — Common Stock (Indirect)
The sale and gift reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on April 3, 2026. The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee. |
Common Stock
(I)
|
16,668 |
| 2026-09-22 | Kleinerman Christian |
EVP, Product Management |
Sell↓
Filing footnotes — Common Stock (Direct)
The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 26, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
2,622 |
| 2026-09-21 | Kleinerman Christian |
EVP, Product Management |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
860 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $330.705 to $331.520, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
2,268 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $333.750 to $334.745, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
25,159 |
| 2026-09-21 | Raghunathan Vivek |
SVP, Engineering |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
3,603 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $335.765 to $336.750, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
9,843 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $338.800 to $339.340, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
2,510 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $337.780 to $338.720, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
7,529 |
| 2026-09-21 | Beaulier Jonathan Mead |
Chief Revenue Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
171 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $334.750 to $335.740, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
25,268 |
| 2026-09-21 | Beaulier Jonathan Mead |
Chief Revenue Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
470 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $332.750 to $333.740, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
5,740 |
| 2026-09-21 | Slootman Frank |
Director |
Convert↑
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
102,791 |
| 2026-09-21 | Ho Emily |
Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
708 |
| 2026-09-21 | Slootman Frank |
Director |
Convert↓
Filing footnotes — Stock Option (Right to Buy) (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The stock option is fully vested. |
Stock Option (Right to Buy)
|
102,791 |
| 2026-09-21 | Beaulier Jonathan Mead |
Chief Revenue Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
70 |
| 2026-09-21 | Ho Emily |
Chief Accounting Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
383 |
| 2026-09-21 | Dageville Benoit |
Director, Founder and Chief Architect |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
535 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $329.540 to $330.510, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
1,936 |
| 2026-09-21 | Ramaswamy Sridhar |
Director, Chief Executive Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
3,415 |
| 2026-09-21 | Kleinerman Christian |
EVP, Product Management |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
1,793 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $336.780 to $337.750, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
15,867 |
| 2026-09-21 | Slootman Frank |
Director |
Sell↓
Filing footnotes — Common Stock (Direct)
The exercises and sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 19, 2025. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $331.730 to $332.725, inclusive. Includes shares to be issued in connection with the vesting of one or more restricted stock units. |
Common Stock
|
6,671 |